加载中
Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
前收盘价
US$58.84
+US$0.92 · +1.59%
盘中时间采用ET。市场数据可能有所延迟。
Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
日内区间
当前US$58.84
52周区间
当前US$58.84
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
18
估值过高
情绪
60
多空交织
风险
44
风险偏高
动量
61
动能增强
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fluorotyper-SARS-CoV-2 plus kits. Beyond life science, Bruker delivers a wide array of specialized instruments for research, analysis, and process control. This includes portable analytical and bioanalytical detection systems, a full range of X-ray instruments (from analytical tools for electron microscopes to handheld, portable, and mobile X-ray fluorescence spectrometry devices), and sophisticated atomic force microscopy (AFM) instrumentation for non-contact nanometer resolution topography. Furthermore, it supplies automated X-ray metrology, automated AFM defect-detection, and equipment for photomask repair and cleaning. The company also excels in advanced optical fluorescence microscopy and provides critical products and services supporting multi-omics research for drug and biomarker discovery. Within its energy sector, Bruker is a key provider of superconducting materials, particularly metallic low-temperature superconductors, and develops complex tools and devices utilizing these materials, alongside other high-technology tools like synchrotron and beamline instrumentation. Reflecting its commitment to innovation, Bruker Corporation collaborates with Newomics Inc. on an LC-MS platform specifically tailored for drug discovery applications. Established in 1991, the corporation maintains its headquarters in Billerica, Massachusetts.
日内区间
当前US$58.84
52周区间
当前US$58.84
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 34.37亿 USD | 33.66亿 USD | 29.65亿 USD | 25.31亿 USD | 24.18亿 USD |
| 销货成本 | 18.59亿 USD | 17.17亿 USD | 14.51亿 USD | 12.25亿 USD | 12.08亿 USD |
| 毛利 | 15.78亿 USD | 16.5亿 USD | 15.13亿 USD | 13.06亿 USD | 12.1亿 USD |
| 研究与开发 | 3.95亿 USD | 3.77亿 USD | 2.95亿 USD | 2.36亿 USD | 2.21亿 USD |
| 销售、一般及管理费用 | 9.47亿 USD | 8.94亿 USD | 7.29亿 USD | 6.07亿 USD | 5.62亿 USD |
| 营业费用 | 13.42亿 USD | 13.96亿 USD | 10.76亿 USD | 8.73亿 USD | 7.96亿 USD |
| 利息收入 | 1480万 USD | 930万 USD | 750万 USD | 280万 USD | 90万 USD |
| 利息支出 | 6030万 USD | 4790万 USD | 1640万 USD | 1610万 USD | 1430万 USD |
| 折旧和摊销 | 2.2亿 USD | 1.84亿 USD | 1.15亿 USD | 8870万 USD | 8910万 USD |
| 营业利润 | 2.36亿 USD | 2.53亿 USD | 4.37亿 USD | 4.33亿 USD | 4.13亿 USD |
| 净利润 | −860万 USD | 1.13亿 USD | 4.27亿 USD | 2.97亿 USD | 2.77亿 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$67.00
上涨空间 13.87%报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1.97亿0.01%2.3万亿 USD0.03%US$381.94+0.63%
Vanguard Morningstar Small-Cap ETFVB1.42亿0.08%1853亿 USD0.03%US$289.48+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR9032.45万0.13%682亿 USD0.05%US$234.43+0.22%
First Trust NYSE Arca Biotechnology Index FundFBT8869.72万3.07%28.91亿 USD0.55%US$265.4+2.00%
Vanguard Extended Market ETFVXF7493.23万0.08%954亿 USD0.05%US$235+0.80%
Dimensional - US Small Cap ETFDFAS6170.72万0.18%338.69亿 USD0.31%US$78.35+0.32%
iShares Biotechnology ETFIBB4982.65万0.47%108.2亿 USD0.44%US$206.49+3.00%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY4829.87万0.19%258.17亿 USD0.23%US$669.87+0.54%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRFirst Trust NYSE Arca Biotechnology Index FundFBTVanguard Extended Market ETFVXFDimensional - US Small Cap ETFDFASiShares Biotechnology ETFIBBState Street SPDR S&P MIDCAP 400 ETF TrustMDYAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
